Amarin Corp Plc (AMRN)

[iwfal]

A tiny, single arm, study was never going to tell them anything unless the patients were dropping like flies.

Your turn

Not really. My case is already essentially proven with the Jelis p value and the very similar ratio of excess bleeds in the Vascepa data. I'd give it >90% chance of excess bleeds in REDUCE IT. I'd give 4:1 odds p value for bleeds is p<0.2.


(Reminder again, that since REDUCE IT is using sicker patients than Jelis, I expect that the CVD reduction n is better than the excess bleeds n. The only question is how much.)